The Patent Finder

Bial - Portela & CA, S.A.

Also on record
Records under this name other than the patents Bial - Portela & CA, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.

Back to Bial - Portela & CA, S.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,907,099Nitrocatechol Derivatives as Comt Inhibitors
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,168,793Nitrocatechol Derivatives as Comt Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,975,410Crystal Forms of 5-[3-(2,5-Dichloro-4, 6-Dimethyl-1-OXY-PYRIDINE-3-YL)[1,2,4] OXADIAZOL-5-YL]-3-Nitrobenzene-1,2-DIOL
Held by another company
In force
 · High confidence
In forceHigh confidence
US 11,434,242Dopamine-B-Hydroxylase Inhibitors
Lapsed on the fee record
Ended Sep 6, 2026 · High confidence
Lapsed on the fee recordEnded Sep 6, 2026High confidence
US 9,550,759Nitrocatechol Derivatives as Comt Inhibitors
Term ended
Term ended Jul 26, 2026 · Medium confidence
Term endedTerm ended Jul 26, 2026Medium confidence
US 10,336,740Nitrocatechol Derivatives as Comt Inhibitors
Term ended
Term ended Jul 26, 2026 · High confidence
Term endedTerm ended Jul 26, 2026High confidence
US 10,023,541Urea Compounds and Their Use as Enzyme Inhibitors
Lapsed on the fee record
Ended Jul 17, 2026 · Medium confidence
Lapsed on the fee recordEnded Jul 17, 2026Medium confidence
US 8,710,239Process for preparing synthetic intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenation
Lapsed on the fee record
Ended Apr 29, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 29, 2026USPTO record
US 9,206,135Asymmetric catalytic reduction of oxcarbazepine
Term ended
Term ended Apr 21, 2026 · USPTO record
Term endedTerm ended Apr 21, 2026USPTO record
US 9,643,929Asymmetric catalytic reduction of oxcarbazepine
Term ended
Ended no later than Apr 21, 2026 · USPTO record
Term endedEnded no later than Apr 21, 2026USPTO record
10 of 42 patents shown.
Pro members see all 42.
Pro members: see all 42 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited